CryoCloud, a Utrecht, the Netherlands-based SaaS biotech startup, raised €2M in Seed funding.
The spherical was led by Nina Capital, with participation from Worth Creation Capital, ROM Utrecht, and Utrecht Well being Seed Fund.
The corporate intends to make use of the funds to automate its product, and additional help its consumer base which exceeds 25 nations and consists of shoppers throughout academia, biotech and pharma firms.
Led by CEO Robert Englmeier, CryoCloud makes use of machine studying and proprietary algorithms to automate cryo-EM information evaluation and make the expertise accessible to researchers and scientists worldwide. Its platform delivers scientists 3D protein visualisations utilizing scalable cloud infrastructure, within the house of hours, reasonably than months. Its automated method makes this expertise accessible to researchers and scientists.
This adopted its pre-Seed spherical of €500K in October 2023, and introduced the overall funding thus far to €2.8M for the reason that enterprise was based in 2021.
FinSMEs
06/05/2025
